Intraperitoneal administration of adenosine for the treatment of prevention of gastrointestinal of systemic diseases
US6566371B2 · kind B2 · utility
3Cited by
2References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 30, 2001 |
| Grant date | May 20, 2003 |
| Priority date | — |
| Expiry date | Apr 30, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7076
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for preventing or treating gastrointestinal or systemic diseases in a mammalian subject, comprising:the step of administering a therapeutically effective amount of a composition comprising adenosine or a prodrug thereof into the peritoneal cavity of said subject at a dose that does not achieve pharmacologically active levels in the aortic arterial plasma of said subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.